Log in | Register

“Does this patient have…” “Is this patient at risk for infection with multidrug resistant bacteria?”

Cristina Vazquez Guillamet| Marin H. Kollef
Editorial
Volume 43, Issue 3 / March , 2017

Pages 436 - 439

No abstract available.

References

  1. Maragakis LL, Perencevich EN, Cosgrove SE (2008) Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther 6:751–763. doi:10.1586/14787210.6.5.751
    • View reference on publisher's website
    • View reference on PubMed
  2. Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474
    • View reference on publisher's website
    • View reference on PubMed
  3. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637. doi:10.1097/CCM.0b013e31827e83af
    • View reference on publisher's website
    • View reference on PubMed
  4. Kollef MH, Micek ST (2012) Antimicrobial stewardship programs: mandatory for all ICUs. Crit Care 16:179. doi:10.1186/cc11853
    • View reference on publisher's website
    • View reference on PubMed
  5. Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH, Forsung E, Kalil AC (2014) Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother 58:5262–5268. doi:10.1128/AAC.02582-14
    • View reference on publisher's website
    • View reference on PubMed
  6. American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416
    • View reference on publisher's website
  7. Shorr AF, Zilberberg MD, Reichley R, Kan J, Hoban A, Hoffman J, Micek ST, Kollef MH (2012) Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 54:193–198. doi:10.1093/cid/cir813
    • View reference on publisher's website
    • View reference on PubMed
  8. Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, Tarsia P, Mantero M, Blasi F (2012) Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 54:470–478. doi:10.1093/cid/cir840
    • View reference on publisher's website
    • View reference on PubMed
  9. Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS (2013) A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug resistant pathogens to select initial empiric therapy. Clin Infect Dis 57:1373–1383. doi:10.1093/cid/cit571
    • View reference on publisher's website
    • View reference on PubMed
  10. Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, Hasegawa Y (2013) Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med 188:985–995. doi:10.1164/rccm.201301-0079OC
    • View reference on publisher's website
    • View reference on PubMed
  11. Falcone M, Russo A, Giannella M, Cangemi R, Scarpellini MG, Bertazzoni G, Alarcón JM, Taliani G, Palange P, Farcomeni A, Vestri A, Bouza E, Violi F, Venditti M (2015) Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia. PLoS ONE 10(4):e0119528. doi:10.1371/journal.pone.0119528(eCollection 2015)
    • View reference on publisher's website
    • View reference on PubMed
  12. Vallés J, Martin-Loeches I, Torres A, Diaz E, Seijas I, López MJ, Garro P, Castillo C, Garnacho-Montero J, Martin Mdel M, de la Torre MV, Olaechea P, Cilloniz C, Almirall J, García F, Jiménez R, Seoane E, Soriano C, Mesalles E, Posada P (2014) Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study. Intensive Care Med 40(4):572–581. doi:10.1007/s00134-014-3239-2
  13. Self WH, Wunderink RG, Williams DJ, Barrett TW, Baughman AH, Grijalva CG (2015) Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia. Acad Emerg Med 22:730–740. doi:10.1111/acem.12672
    • View reference on publisher's website
    • View reference on PubMed
  14. Chalmers JD, Rother C, Salih W, Ewig S (2014) Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis 58:330–339. doi:10.1093/cid/cit734
    • View reference on publisher's website
    • View reference on PubMed
  15. Garcia-Vidal C, Viasus D, Roset A, Adamuz J, Verdaguer R, Dorca J, Gudiol F, Carratalà J (2011) Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 17:1659–1665. doi:10.1111/j.1469-0691.2011.03484.x
    • View reference on publisher's website
    • View reference on PubMed
  16. Sibila O, Laserna E, Maselli DJ, Fernandez JF, Mortensen EM, Anzueto A, Waterer G, Restrepo MI (2015) Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia. Respirology 20(4):660–666. doi:10.1111/resp.12506(Epub 2015 Mar 16)
    • View reference on publisher's website
    • View reference on PubMed
  17. Kollef MH (2014) What can be expected from antimicrobial de-escalation in the critically ill? Intensive Care Med 40:92–95. doi:10.1007/s00134-013-3154-y

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement